![John McKearn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John McKearn
Chairman at Arch Oncology, Inc.
Net worth: 135 199 $ as of 30/05/2024
Network origin in John McKearn first degree
Entity | Entity type | Industry | |
---|---|---|---|
The University of Chicago
240
| College/University | Other Consumer Services | 240 |
Pharmacia Corp.
![]() Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
107
| Extinct | Pharmaceuticals: Major | 107 |
Northern Illinois University
44
| College/University | Other Consumer Services | 44 |
24
| Public Company | Pharmaceuticals: Major | 24 |
RiverVest Venture Management LLC
![]() RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri with additional offices in San Diego and Cleveland.
24
| Private Company | Investment Managers | 24 |
22
| Private Company | Biotechnology | 22 |
IDM Pharma, Inc.
![]() IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA.
16
| Extinct | Pharmaceuticals: Major | 16 |
Kalypsys, Inc.
![]() Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA.
12
| Extinct | Pharmaceuticals: Major | 12 |
Wugen, Inc.
![]() Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO.
11
| Holding Company | Packaged Software | 11 |
Arch Oncology, Inc.
![]() Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
OncoResponse, Inc.
![]() OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.
7
| Holding Company | Biotechnology | 7 |
Subsidiary | Chemicals: Agricultural | 7 | |
Bonum Therapeutics, Inc.
![]() Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Bonum Therapeutics, Inc. is a privately held American company that focuses on generating a new class of therapeutics based on a proven technology platform. Bonum Therapeutics is based in an undisclosed location and was founded in 2022 by the Good Therapeutics team. The company's technology utilizes principles of allosteric regulation to create highly active and less toxic medicines, which can be applied to a wide range of therapeutic areas, including oncology, autoimmunity, metabolic disorders, and pain management. The company's molecules combine a sensor component directed against a specific biological marker and a therapeutic component. The company is backed by a group of leading venture investors, including Codon Capital, Roche Venture Fund, RiverVest Venture Partners, 3x5 Partners, Digitalis Ventures, and Vivo Capital. The company was founded by John Mulligan, who has been the CEO since incorporation.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
G.D. Searle LLC
6
| Subsidiary | 6 | |
Good Therapeutics, Inc.
![]() Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Good Therapeutics, Inc. operates as a biotechnology company. It develops "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. The company was founded by John Mulligan in 2016 and is headquartered in Seattle, WA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
OxaluRx, Inc.
2
| Holding Company | Miscellaneous | 2 |
Searle & Co., Inc.
![]() Searle & Co., Inc. Investment ManagersFinance Searle & Co., Inc. provides investment advisory services. The business continuity plan addresses data back up and recovery, all mission critical systems, financial and operational assessments, alternative communications with customers, employees, regulators, alternate physical location of employees, critical supplier, contractor, bank and counter-party impact, regulatory reporting and assuring their customers prompt access to their funds and securities if they are unable to continue their business. The company was founded in 1982 and is headquartered in Greenwich, CT
2
| Private Company | Investment Managers | 2 |
Basel Institute for Immunology
2
| College/University | Other Consumer Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John McKearn via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
Roche Ventures
![]() Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
3x5 Partners LLC
![]() 3x5 Partners LLC Investment ManagersFinance 3x5 Partners LLC (3x5 Partners) is a venture capital firm founded in 2011 by Tony Arnerich and Nicholas Walrod. The firm is headquartered in Portland, Oregon. | Investment Managers | Director of Investments Director of Investments Private Equity Investor Founder | |
Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
University of California, Irvine | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Theraclone Sciences, Inc.
![]() Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Executive Officer | |
Federal Reserve System | General Government | Economist Corporate Officer/Principal Investment Committee Member | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Director/Board Member | |
Georgetown University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
Alta Partners Management Co. LP
![]() Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor Director/Board Member Private Equity Investor | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Consultant / Advisor Corporate Officer/Principal Private Equity Investor | |
Indiana University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
University of Michigan | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
EXICURE, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
University of Wisconsin | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
INTUITIVE SURGICAL, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
ZS PHARMA INC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Securus Medical Group, Inc.
![]() Securus Medical Group, Inc. Medical SpecialtiesHealth Technology Securus Medical Group, Inc. develops clinical tools to monitor core body temperature within body cavities. The firm develops tissue temperature monitoring and mapping systems. The company was founded by John T. Garibotto on June 24, 2011 and is headquartered in Cleveland, OH. | Medical Specialties | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
DESIGN THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Comptroller/Controller/Auditor | |
SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree Doctorate Degree | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
SARcode Bioscience, Inc.
![]() SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Conventus Orthopaedics, Inc.
![]() Conventus Orthopaedics, Inc. Hospital/Nursing ManagementHealth Services Conventus Orthopaedics, Inc. operates as a medical device company for fracture treatment. It focuses on creating less invasive solutions for fractures in and around the joints. The firm offers distal radial and wrist fracture repair products. Its products include distal radius and proximal humerus. The company was founded by Michael P. Brenzel and Paul J. Hindrichs in 2009 and is headquartered in Maple Grove, MN. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
SYNTHORX, INC. | Biotechnology | Director/Board Member Chairman | |
HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Rady School of Management at UC San Diego | College/University | Masters Business Admin Masters Business Admin | |
Pivotal Bioventure Partners Investment Advisor LLC
![]() Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Glycomine, Inc.
![]() Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Brigham Young University | College/University | Undergraduate Degree Undergraduate Degree | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member |
Statistics
International
United States | 47 |
United Kingdom | 3 |
Switzerland | 2 |
Ireland | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 14 |
Finance | 6 |
Commercial Services | 3 |
Government | 2 |
Operational
Director/Board Member | 597 |
Corporate Officer/Principal | 195 |
Independent Dir/Board Member | 139 |
Chairman | 97 |
Undergraduate Degree | 83 |
Most connected contacts
Insiders | |
---|---|
Steven Gillis | 58 |
Daniel Janney | 47 |
Timothy Walbert | 40 |
Carol Gallagher | 39 |
Michael Berman | 38 |
Chau Khuong | 38 |
Heather Elizabeth Preston | 34 |
Wende Hutton | 31 |
Fred Hassan | 30 |
Bobby Sandage | 29 |
Vickie Capps | 28 |
Peter Bisgaard | 28 |
Carole Nüchterlein | 27 |
Peter Kiener | 25 |
Steven James | 24 |
- Stock Market
- Insiders
- John McKearn
- Company connections